JPMorgan downgrades Light & Wonder stock rating on growth concerns

JPMorgan downgraded Light & Wonder (LNW) to Neutral and reduced its price target to $95, citing skepticism regarding the company's ability to organically achieve its revised FY25 EBITDA guidance of $1.43B-$1.47B, which now incorporates the Grover acquisition and requires an aggressive 15% growth in the second half of 2025. This downgrade reflects concerns over the core business's organic growth trajectory, potential free cash flow challenges, and gearing, despite LNW reporting a Q2 2025 EPS of $1.58 that exceeded analyst expectations, though it missed revenue forecasts.

Analysis

JPMorgan has downgraded Light & Wonder (LNW) from Overweight to Neutral, cutting its price target to $95 from $108, due to skepticism over the company's ability to achieve its FY25 EBITDA targets through organic growth. The firm's revised guidance of $1.43 billion to $1.47 billion now incorporates contributions from the Grover acquisition, implying the original organic target of $1.4 billion is at risk. Achieving the new guidance midpoint requires an estimated 15% EBITDA growth in the second half of 2025, a significant acceleration compared to the 11% growth in Q1 and 7% in Q2 2025. This deceleration in core growth underpins JPMorgan's concerns. This cautious outlook is further compounded by potential challenges to free cash flow and gearing. While the company recently reported a strong Q2 EPS of $1.58, beating estimates by 16.18%, it simultaneously missed revenue forecasts, reporting $809 million against an expected $851.13 million, presenting a mixed operational picture.

Key Decisions for Investors

• Investors should re-evaluate LNW's growth profile, considering the increased reliance on the Grover acquisition to meet targets, as highlighted by JPMorgan's downgrade.
• Monitor future earnings reports for evidence of the required 15% EBITDA growth acceleration in H2 2025, as failure to achieve this would validate concerns about slowing organic momentum.
• Pay close attention to management's commentary on free cash flow conversion and balance sheet gearing, as these were identified as specific potential risks.
• Despite the strong Q2 EPS beat, the revenue miss and analyst downgrade suggest it may be prudent to wait for more clarity on a sustainable organic growth path before initiating or adding to positions.